Filing Flows

Filing Flows › Intelligent Bio Solutions (INBS) › Who owns the stock

Who owns Intelligent Bio Solutions (INBS) stock

8 funds reported Intelligent Bio Solutions (INBS) shares in their latest 13F filings, worth $438K in all. The largest holder is Armistice Capital, LLC ($325K). Last quarter 2 funds added to their stakes and 5 cut them.

Largest holders of INBS (13F)Largest holders of INBS (13F)Armistice Capital, LLC$325KGeode Capital Management, LLC$48KStoneX Group$23KVanguard Capital Management LLC$13KUBS Group AG$13KVanguard Fiduciary Trust$9KTower Research Capital LLC$8KOsaic Holdings$460

Largest holders (13F)

FundSharesValueChangeQuarter
Armistice Capital, LLC141,397$325Kincrease2026-06-30
Geode Capital Management, LLC20,840$48Kdecrease2026-06-30
StoneX Group11,217$23Knew2026-09-30
Vanguard Capital Management LLC5,810$13Kunchanged2026-06-30
UBS Group AG5,735$13Kincrease2026-06-30
Vanguard Fiduciary Trust3,958$9Kunchanged2026-06-30
Tower Research Capital LLC3,280$8Kincrease2026-06-30
Osaic Holdings200$460unchanged2026-06-30

Intelligent Bio Solutions' latest quarter

Intelligent Bio Solutions, Q4 FY26: revenue $1.1M (+36% year over year), operating margin -346.4%, net loss $3.9M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most INBS stock?

By the latest 13F filings: Armistice Capital, LLC ($325K); Geode Capital Management, LLC ($48K); StoneX Group ($23K); Vanguard Capital Management LLC ($13K); UBS Group AG ($13K).

What is the short interest in INBS?

91,113 shares were sold short at the 2026-10-15 settlement, 56.3% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.